DOI: 10.4103/jpbs.jpbs_399_23 ISSN: 0976-4879

A Study Comparing Centchroman and Evening Primrose Oil in the Treatment of Benign Breast Disease

Nirupam Sinha, Yasir Tajdar, Deepak Pankaj, Nitesh Kumar, Sweta Muni, Vibhuti Bhushan
  • General Pharmacology, Toxicology and Pharmaceutics
  • General Biochemistry, Genetics and Molecular Biology
  • Bioengineering
  • General Pharmacology, Toxicology and Pharmaceutics
  • General Biochemistry, Genetics and Molecular Biology
  • Bioengineering
Show PDF Cite

A
BSTRACT

Introduction:

Females seeking medical attention at breast clinics commonly present with nonmalignant breast conditions, including nonspecific breast pain or distinct masses like fibroadenomas. Due to its variability, it may be difficult to quantify breast pain. The purpose of the research was to compare centchroman and evening primrose oil to identify a cost-effective, secure, and efficient treatment for benign breast disease.

Material and Methods:

In this prospective hospital-based observational study, 100 breast diseases with or without lumpiness for 1 year were included and divided into two groups with 50 cases each, Group-A (Centchroman) and Group-B (Evening primrose oil).

Results:

Centchroman exhibited a significantly greater treatment response for alleviating pain-free mastalgia compared to evening primrose oil. Additionally, centchroman showed an excellent response (P < .05). Among participants with mastalgia, centchroman significantly reduced the number of mastalgia patients with tender nodularity post-treatment (P = .035) than evening primrose oil. On the basis of fibroadenoma, partial and complete response was significantly seen in higher number of cases in the centchroman group (P = .007).

Conclusion:

Centchroman therapy demonstrates that the treatment for benign breast disease is safe, effective, and economical.

More from our Archive